background image

Paid Clinical Trials Wisconsin

Discover 1,187 paid clinical trials in Wisconsin. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study to Evaluate the Effect of Aficamten in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

Recruiting
PHASE2
PHASE3

Sponsor:

Cytokinetics

Location:

Milwaukee WI, Rochester MN, Chicago IL, Iowa City IAshow 18 more

Code:

NCT06412666

Conditions

Pediatric

Symptomatic Obstructive Hypertrophic Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Aficamten

Placebo

Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion

Recruiting

Sponsor:

Han Joo Lee

Location:

Milwaukee WI

Code:

NCT06731426

Conditions

OCD

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CBM-TAF

CBM-SMP

Mental Health App for Cancer Survivors Study

Recruiting

Sponsor:

University of Wisconsin, Madison

Location:

Madison WI

Code:

NCT06472726

Conditions

Head and Neck Cancer

Head and Neck Cancers

Depression

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Not accepted

Interventions

IONA Mind app

The Arteriovenous Vascular (AV) ACCESS Trial

Recruiting

Sponsor:

Wake Forest University Health Sciences

Location:

Madison WI, Knoxville TN, Winston-Salem NC, Baltimore MDshow 3 more

Code:

NCT04646226

Conditions

End-Stage Kidney Disease

Hemodialysis Complication

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Interventions

AV graft

surgical intervention for creation of a fistula

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Recruiting
PHASE1
PHASE2

Sponsor:

C4 Therapeutics, Inc.

Location:

Milwaukee WI, Rochester MN, Saint Louis MO, Nashville TNshow 7 more

Code:

NCT04756726

Conditions

Multiple Myeloma

Lymphoma, Non-Hodgkin's

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemsidomide

Dexamethasone Oral

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Recruiting
PHASE3

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Madison WI, Rochester MN, Fort Wayne IN, Ann Arbor MIshow 45 more

Code:

NCT04045665

Conditions

Atrial Fibrillation

Stroke

Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Antiplatelet-only strategy

Oral Anticoagulant plus background antiplatelet therapy

KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment

Recruiting
PHASE2
PHASE3

Sponsor:

Kartos Therapeutics, Inc.

Location:

Milwaukee WI, Chicago IL, Sioux Falls SD, Saint Louis MOshow 14 more

Code:

NCT03662126

Conditions

Primary Myelofibrosis (PMF)

Post-Polycythemia Vera MF (Post-PV-MF)

Post-Essential Thrombocythemia MF (Post-ET-MF)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KRT-232

Best Available Therapy (BAT)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Wisconsin Rapids WI, Stevens Point WI, Waupaca WI, Marshfield WIshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Madison WI, Milwaukee WI, Rochester MN, Minneapolis MNshow 103 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Recruiting
PHASE2

Sponsor:

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Location:

Madison WI, Rochester MN, Chicago IL, Iowa City IAshow 34 more

Code:

NCT06297226

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Arlocabtagene Autoleucel (BMS-986393)

Popular cities in Wisconsin

The state of Wisconsin offers a substantial healthcare network and renowned medical research institutions, making it a prime location for clinical research into a variety of conditions. Leading centers such as the University of Wisconsin School of Medicine and Public Health, the Medical College of Wisconsin, and Froedtert Hospital are state leaders in medical research. These institutions, known for their innovative approaches, provide a strong foundation for conducting clinical trials that advance medical knowledge and treatment options.

Why choose Wisconsin for clinical trials?

Common conditions studied in Wisconsin

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Wisconsin